MX360905B - Polimixinas, composiciones, metodos de preparacion y metodos de uso. - Google Patents
Polimixinas, composiciones, metodos de preparacion y metodos de uso.Info
- Publication number
- MX360905B MX360905B MX2015008878A MX2015008878A MX360905B MX 360905 B MX360905 B MX 360905B MX 2015008878 A MX2015008878 A MX 2015008878A MX 2015008878 A MX2015008878 A MX 2015008878A MX 360905 B MX360905 B MX 360905B
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- polymyxins
- compositions
- making
- xch2n
- Prior art date
Links
- 108010040201 Polymyxins Proteins 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940041153 polymyxins Drugs 0.000 title 1
- -1 -CH2CH(CH3)2 Chemical group 0.000 abstract 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
Abstract
La presente invención se refiere a una composición que comprende cuando menos una polimixina o una sal de ésta representada por la fórmula (I). (ver Fórmula) en donde: R1 es un grupo acilo C6-C10 alifático, ramificado o lineal, o (ver Fórmula) R5 es -CH(CH3)2, -CH2CH(CH3)2, -CH(CH3)CH2CH3, o -CH2C6H5; R6 es -CH(CH3)2, -CH2CH(CH3)2, o -CH(CH3)CH2CH3; cada uno de R2,R3,R4, R7 y R8 es ya sea -(CH2)XCH2NH2 o - (CH2)XCH2N(CH2SO3M)2; en donde x es 0 o 1;en donde M es un catión monovalente; y en donde cuando menos tres de R2,R3,R4,R7 y R8 son -(CH2)XCH2N(CH2SO3M)2.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361751341P | 2013-01-11 | 2013-01-11 | |
| US201361904793P | 2013-11-15 | 2013-11-15 | |
| PCT/EP2014/050320 WO2014108469A1 (en) | 2013-01-11 | 2014-01-09 | Polymyxins, compositions, methods of making and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015008878A MX2015008878A (es) | 2015-10-30 |
| MX360905B true MX360905B (es) | 2018-11-21 |
Family
ID=50101865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015008878A MX360905B (es) | 2013-01-11 | 2014-01-09 | Polimixinas, composiciones, metodos de preparacion y metodos de uso. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10640536B2 (es) |
| EP (1) | EP2943503B1 (es) |
| JP (1) | JP6316846B2 (es) |
| KR (1) | KR20150107793A (es) |
| CN (1) | CN104918951B (es) |
| AU (1) | AU2014204873B2 (es) |
| BR (1) | BR112015016548A2 (es) |
| CA (1) | CA2895910C (es) |
| EA (1) | EA027067B1 (es) |
| ES (1) | ES2641017T3 (es) |
| HU (1) | HUE034562T2 (es) |
| IL (1) | IL239840A (es) |
| MX (1) | MX360905B (es) |
| PT (1) | PT2943503T (es) |
| RU (1) | RU2015132569A (es) |
| SI (1) | SI2943503T1 (es) |
| TW (1) | TWI613219B (es) |
| UA (1) | UA117673C2 (es) |
| WO (1) | WO2014108469A1 (es) |
| ZA (1) | ZA201504565B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA027067B1 (ru) | 2013-01-11 | 2017-06-30 | Кселлия Фармасьютикалз Апс | Полимиксины, композиции, способы получения и способы применения |
| TW201522364A (zh) * | 2013-06-07 | 2015-06-16 | Xellia Pharmaceuticals Aps | 黏菌素甲磺酸鈉（ｃｍｓ）之定性方法 |
| JP2017523953A (ja) | 2014-07-09 | 2017-08-24 | クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ | 低置換度ポリミキシン及びその組成物 |
| RS60874B1 (sr) | 2014-10-03 | 2020-11-30 | Xellia Pharmaceuticals Aps | Kompozicije |
| SG11201702666SA (en) | 2014-10-03 | 2017-04-27 | Xellia Pharmaceuticals Aps | Inhalation device |
| WO2016100578A2 (en) | 2014-12-16 | 2016-06-23 | Micurx Pharmaceuticals, Inc. | Antimicrobial polymyxins for treatment of bacterial infections |
| FI126143B (en) * | 2015-01-15 | 2016-07-15 | Northern Antibiotics Oy | Polymyxine derivative and its uses |
| AU2016331658B2 (en) * | 2015-09-29 | 2021-04-01 | Monash University | Antimicrobial polymyxin derivative compounds |
| CN109996806B (zh) * | 2016-12-09 | 2021-11-02 | 正大天晴药业集团股份有限公司 | 高效价的多黏菌素e2甲磺酸钠 |
| CN115298198A (zh) | 2020-01-21 | 2022-11-04 | 上海盟科药业股份有限公司 | 用于肾相关癌症靶向治疗的新型化合物和组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1062895A (en) | 1962-12-13 | 1967-03-22 | Wellcome Found | Sulphomethyl derivatives of polymxin |
| FR1586834A (es) | 1968-02-12 | 1970-03-06 | ||
| DE1906699A1 (de) | 1968-02-12 | 1970-02-05 | Pfizer | Neue Polymyxinderivate und Verfahren zu deren Herstellung |
| EP0362370A1 (en) * | 1988-04-07 | 1990-04-11 | Edward Shanbrom | Non-thrombogenic intravascular time release catheter |
| ATE202481T1 (de) | 1996-11-15 | 2001-07-15 | Pathogenesis Corp | Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege |
| US5767068A (en) | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| ES2261735T3 (es) | 2001-05-18 | 2006-11-16 | Chiron Corporation | Sistema para la administracion de una formulacion de tobramicina. |
| US20040022740A1 (en) | 2001-07-10 | 2004-02-05 | Baker William R. | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| EP1940859A1 (en) * | 2005-10-28 | 2008-07-09 | Arch Pharmalabs Limited | An improved process for preparation of gemcitabine hydrochloride |
| WO2008025560A1 (en) | 2006-09-01 | 2008-03-06 | Pari Pharma Gmbh | Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy |
| US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| WO2012168820A1 (en) | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
| EA027067B1 (ru) | 2013-01-11 | 2017-06-30 | Кселлия Фармасьютикалз Апс | Полимиксины, композиции, способы получения и способы применения |
| TW201522364A (zh) | 2013-06-07 | 2015-06-16 | Xellia Pharmaceuticals Aps | 黏菌素甲磺酸鈉（ｃｍｓ）之定性方法 |
| JP2017523953A (ja) | 2014-07-09 | 2017-08-24 | クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ | 低置換度ポリミキシン及びその組成物 |
| RS60874B1 (sr) | 2014-10-03 | 2020-11-30 | Xellia Pharmaceuticals Aps | Kompozicije |
-
2014
- 2014-01-09 EA EA201591280A patent/EA027067B1/ru unknown
- 2014-01-09 WO PCT/EP2014/050320 patent/WO2014108469A1/en not_active Ceased
- 2014-01-09 ES ES14704292.3T patent/ES2641017T3/es active Active
- 2014-01-09 JP JP2015552046A patent/JP6316846B2/ja active Active
- 2014-01-09 MX MX2015008878A patent/MX360905B/es active IP Right Grant
- 2014-01-09 RU RU2015132569A patent/RU2015132569A/ru not_active Application Discontinuation
- 2014-01-09 HU HUE14704292A patent/HUE034562T2/en unknown
- 2014-01-09 AU AU2014204873A patent/AU2014204873B2/en active Active
- 2014-01-09 EP EP14704292.3A patent/EP2943503B1/en active Active
- 2014-01-09 CN CN201480004714.8A patent/CN104918951B/zh active Active
- 2014-01-09 UA UAA201507907A patent/UA117673C2/uk unknown
- 2014-01-09 US US14/760,222 patent/US10640536B2/en active Active
- 2014-01-09 SI SI201430386T patent/SI2943503T1/sl unknown
- 2014-01-09 KR KR1020157021592A patent/KR20150107793A/ko not_active Withdrawn
- 2014-01-09 PT PT147042923T patent/PT2943503T/pt unknown
- 2014-01-09 CA CA2895910A patent/CA2895910C/en active Active
- 2014-01-09 BR BR112015016548A patent/BR112015016548A2/pt not_active Application Discontinuation
- 2014-01-10 TW TW103101009A patent/TWI613219B/zh active
-
2015
- 2015-06-24 ZA ZA2015/04565A patent/ZA201504565B/en unknown
- 2015-07-08 IL IL239840A patent/IL239840A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150107793A (ko) | 2015-09-23 |
| EP2943503A1 (en) | 2015-11-18 |
| RU2015132569A (ru) | 2017-02-14 |
| CN104918951A (zh) | 2015-09-16 |
| ES2641017T3 (es) | 2017-11-07 |
| JP2016505007A (ja) | 2016-02-18 |
| SI2943503T1 (sl) | 2017-11-30 |
| CA2895910A1 (en) | 2014-07-17 |
| US10640536B2 (en) | 2020-05-05 |
| TW201429995A (zh) | 2014-08-01 |
| US20160002296A1 (en) | 2016-01-07 |
| CA2895910C (en) | 2021-12-21 |
| UA117673C2 (uk) | 2018-09-10 |
| AU2014204873A1 (en) | 2015-07-09 |
| AU2014204873B2 (en) | 2017-07-06 |
| MX2015008878A (es) | 2015-10-30 |
| IL239840A (en) | 2017-09-28 |
| IL239840A0 (en) | 2015-08-31 |
| EA201591280A1 (ru) | 2015-12-30 |
| HUE034562T2 (en) | 2018-03-28 |
| JP6316846B2 (ja) | 2018-04-25 |
| EA027067B1 (ru) | 2017-06-30 |
| EP2943503B1 (en) | 2017-08-23 |
| CN104918951B (zh) | 2018-03-30 |
| TWI613219B (zh) | 2018-02-01 |
| WO2014108469A1 (en) | 2014-07-17 |
| ZA201504565B (en) | 2016-11-30 |
| PT2943503T (pt) | 2017-09-28 |
| BR112015016548A2 (pt) | 2017-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX360905B (es) | Polimixinas, composiciones, metodos de preparacion y metodos de uso. | |
| MX2015009591A (es) | Amidas como moduladores de canales de sodio. | |
| NZ716840A (en) | Combination formulation of two antiviral compounds | |
| CU24377B1 (es) | Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting | |
| BR112014011938A2 (pt) | combinação de formulação de dois compostos antivirais | |
| MA38982A1 (fr) | Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl | |
| BR112018003026A2 (pt) | composições compreendendo um inibidor de pi3k e um inibidor de hdac | |
| IN2015MN00405A (es) | ||
| EA201500653A1 (ru) | Композиции, содержащие триазольное соединение | |
| CR20140091A (es) | Nuevos derivados dihidroquinolina-2-ona | |
| PH12017500513A1 (en) | N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of nr2b | |
| MX373622B (es) | Mezclas de compuestos, su preparación y sus usos. | |
| MX356342B (es) | Agente de control de endoparásitos y método para usarlo. | |
| MX2015013530A (es) | Mezclas de alquilpoliglucósidos, su preparacion y sus usos. | |
| MX2016005993A (es) | Anfifilos biscationicos y triscationicos como agentes antimicrobianos. | |
| DOP2014000178A (es) | Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2 | |
| MX2017011978A (es) | Analogos deuterados de etifoxina, sus derivados y usos de estos. | |
| SG10201803294PA (en) | Tau imaging probe | |
| MY179145A (en) | Skin cleansing composition | |
| NZ703217A (en) | Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same | |
| MA58019B1 (fr) | Thienyloxazolones et analogues | |
| UY37443A (es) | Derivados de fenilamina sustituidos en la posición 4 y uso de los mismos para proteger los cultivos combatiendo los microorganismos fitopatógenos no deseados | |
| SG10201805880UA (en) | Emulsion composition for skin | |
| PH12018500695A1 (en) | Oral care compositions and methods of using the compositions | |
| MX380583B (es) | Insecticidas de 1-aril-3-alquilpirazol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |